Journal article
Nano-scale gene delivery systems: current technology, obstacles, and future directions
- Abstract:
- Within the different applications of nanomedicine currently being developed, nanogene delivery is appearing as an exciting new technique with the possibility to overcome recognised hurdles and several biological and medical needs. The central component of all delivery systems is the requirement for the delivery of genetic material into cells, and for them to eventually reside in the nucleus where their desired function will be exposed. However, genetic material does not passively enter cells; thus, a delivery system is necessary. The emerging field of nano-gene delivery exploits the use of new materials and the properties that arise at the nanometre-scale to produce delivery vectors that can effectively deliver genetic material into a variety of different types of cells. The novel physicochemical properties of the new delivery vectors can be used to address the current challenges existing in nucleic acid delivery in vitro and in vivo. While there is a growing interest in nanostructure-based gene delivery, the field is still in its infancy, and there is yet much to discover about nanostructures and their physicochemical properties in a biological context. We carried out an organised and focused search of bibliographic databases. Our results suggest that despite new breakthroughs in nanostructure synthesis and advanced characterization techniques, we still face many barriers in producing highly efficient and non-toxic delivery systems. In this review, we overview the types of systems currently used for clinical and biomedical research applications along with their advantages and disadvantages, as well as discussing barriers that arise from nano-scale interactions with biological material. In conclusion, we hope that by bringing the far reaching multidisciplinary nature of nano-gene delivery to light, new targeted nanotechnology-bases strategies are developed to overcome the major challenges covered in this review.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 535.0KB, Terms of use)
-
- Publisher copy:
- 10.2174/0929867325666180108100723
Authors
+ Engineering and Physical Sciences Research Council
More from this funder
- Funding agency for:
- Dunwell, T
- Grant:
- IAA D4D00620
+ “la Caixa” Banking Foundation,
Barcelona, Spain
More from this funder
- Funding agency for:
- Garcia-Guerra, A
- Grant:
- “la Caixa” Fellowship Grant for Post-Graduate Studies
- Publisher:
- Bentham Science Publishers
- Journal:
- Current Medicinal Chemistry More from this journal
- Volume:
- 25
- Issue:
- 21
- Pages:
- 2448-2464
- Publication date:
- 2018-01-08
- Acceptance date:
- 2017-11-28
- DOI:
- EISSN:
-
1875-533X
- ISSN:
-
0929-8673
- Pmid:
-
29308734
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:817666
- UUID:
-
uuid:c6403a35-caf4-43b3-8645-9f05724a8066
- Local pid:
-
pubs:817666
- Source identifiers:
-
817666
- Deposit date:
-
2018-07-25
Terms of use
- Copyright holder:
- Bentham Science Publishers
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 Bentham Science Publishers. This is the accepted manuscript version of the article. The final version is available online from Bentham Science Publishers at: https://doi.org/10.2174/0929867325666180108100723
If you are the owner of this record, you can report an update to it here: Report update to this record